Hangzhou Diagens Biotechnology Co., Ltd. (HKG:2526)

Hong Kong · Delayed Price · Currency is HKD

526.00

+104.20 (24.70%)

Aug 21, 2026, 4:08 PM HKT

HKG:2526 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Revenue	183.31	164.42	70.35	52.84
Revenue Growth	160.56%	133.72%	33.13%	-
Gross Profit	127.97	118.09	46.06	37.5
Operating Income	-115.92	-80.57	-32.09	-44.19
Net Income	-121.68	-67.14	-43.38	-56.12
Earnings Per Share	-1.47	-0.84	-0.55	-0.74
EPS Growth	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cash & Investments	654.59	45.46	58.6	84.53
Total Debt	55.68	5.92	19.12	4.5
Net Cash (Debt)	598.9	39.54	39.48	80.03
Net Cash Growth	1417.02%	0.16%	-50.67%	-
Net Cash Per Share	7.22	0.49	0.50	1.05

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Operating Cash Flow	-152.37	-50.54	-29.78	-47.4
Capital Expenditures	-3.71	-7.47	-24.2	-24.22
Free Cash Flow	-156.08	-58	-53.98	-71.61
Free Cash Flow Growth	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Gross Margin	69.81%	71.82%	65.47%	70.95%
Operating Margin	-63.24%	-49.00%	-45.62%	-83.62%
Pretax Margin	-66.37%	-40.83%	-61.67%	-106.32%
Profit Margin	-66.38%	-40.83%	-61.65%	-106.19%
FCF Margin	-85.15%	-35.28%	-76.72%	-135.52%